A school-based scientific study in Italy, Austria, Germany, Slovenia, Mauritius and Japan shows that young people know too little about reciprocal disease transmission from animals to […]
A study released today in Stem Cells Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung […]
A new study, published in JCI Insight, looks at how Brd4, a regulator of the innate immune response, influences diet-induced obesity. The researchers believe that Brd4 […]
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.